Cargando…
Lipid-lowering and kidney
Autor principal: | Lee, Sang-Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407637/ https://www.ncbi.nlm.nih.gov/pubmed/37448278 http://dx.doi.org/10.23876/j.krcp.23.104 |
Ejemplares similares
-
Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023) -
Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012) -
Role of lipid-lowering agents in the management of diabetic retinopathy
por: Ioannidou, Estelle, et al.
Publicado: (2017) -
Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013) -
Have we reached the bottom of the bottomless pit- lessons from the recent lipid-lowering trials?
por: Bansal, Manish, et al.
Publicado: (2018)